US CDC Panel Recommends Some 50-59 Year-Olds For RSV Vaccination

The CDC's ACIP expanded the population for adult RSV vaccines and soon could weigh a new option for pediatrics. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Product Reviews